Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial.

Comella, P; Massidda, B; Filippelli, G; Palmeri, S; Natale, D; Farris, A; De Vita, F; Buzzi, F; Tafuto, S; Maiorino, L; Mancarella, S; Leo, S; Lorusso, V; De Lucia, L; Roselli, M

Comella, P; Massidda, B; Filippelli, G; Palmeri, S; Natale, D; Farris, A; De Vita, F; Buzzi, F; Tafuto, S; Maiorino, L; Mancarella, S; Leo, S; Lorusso, V; De Lucia, L; Roselli, M.

Affiliation

Comella P; Department of Medical Oncology, National Tumour Institute, Naples, Italy. pasqualecomella@libero.it

Ann Oncol ; 16(6): 878-86, 2005 Jun.

Article de En | MEDLINE | ID: mdl-15837702

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs colorectales / Protocoles de polychimiothérapie antinéoplasique Type d'étude: Clinical_trials Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2005 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links